Healthcare
Synaptiq Combines AI Tumor and Organ Contouring to Speed Radiotherapy Planning

Key PointsMediq RT's reported 92.6% contouring time reduction includes clinician review and…
View more
- Mediq RT's reported 92.6% contouring time reduction includes clinician review and correction rather than raw AI inference alone.
- Synaptiq's separate benchmark comparison uses the same 80-patient dataset as a 2023 study that did not include its system.
- Mediq RT exports reviewed structures through DICOM but does not independently prescribe or deliver radiation.
Synaptiq is bringing AI-assisted tumor delineation and organ-at-risk contouring into a single radiotherapy planning workflow with its Mediq RT platform. The Romanian health-tech company says a clinical evaluation found an average 92.6% reduction in CT contouring time, including the time clinicians spent reviewing and correcting the AI’s work.
The November 18 announcement centers on an important step before radiation treatment: outlining the target and the healthy structures that clinicians need to protect. Synaptiq says Mediq RT combines automatic segmentation with interactive refinement, allowing specialists to guide the contours while retaining responsibility for their approval.
The company announced a Class IIa CE mark under the EU Medical Device Regulation specifically covering tumor contouring. That provides the regulatory context for the expansion, while the practical proposition for radiotherapy departments is a shorter path from scan to reviewed contours.
Turning CT Images Into Editable Structures
Contouring converts medical images into defined regions that a treatment-planning system can use. Tumor targets and nearby organs serve different purposes: one identifies the tissue to treat, while the others help the clinical team manage exposure to healthy anatomy.
Mediq RT’s AI contouring software generates these structures for clinicians to inspect and adjust. Synaptiq says the platform supports more than 250 organs-at-risk and lymph node regions across anatomical cancer sites, with initial contour processing taking approximately 30 seconds per patient.
The interactive component, called Active Intelligence, gives clinicians a way to refine a result without redrawing every slice. On its website, Synaptiq describes a workflow in which a radiation oncologist outlines one slice of a gross tumor volume, and the AI extends the contour through the remaining volume. Corrections on an individual slice can also guide AI-assisted revisions.
The new announcement puts the model’s response to interactive prompts at approximately one to two seconds. That response time, the initial processing time and the time required to review a complete case describe different parts of the workflow.
“With Mediq RT, we’re reducing the time clinicians spend on treatment planning by bringing tumour and organ contouring together in one place, while keeping clinicians in control of every decision,” said Dragoș Dușe, CEO and co-founder of Synaptiq.
What the Reported Time Savings Measure
According to Synaptiq, the clinical evaluation assessed as part of its conformity assessment covered head-and-neck, thorax, abdomen and pelvis CT cases. Its reported average 92.6% time reduction compares the clinician-reviewed workflow with manual contouring, rather than comparing manual work with raw AI inference alone.
The largest reduction was in head-and-neck cases: average contouring time fell from 97 minutes manually to 2.7 minutes with Mediq RT, a reported 97.2% decrease. Across the CT evaluation, the company says 92.1% of AI-generated contours were accepted without edits, 7.6% needed minor edits and fewer than 0.3% needed major corrections.
Those are measures of contouring efficiency and clinical acceptability within the evaluation. They do not, by themselves, establish a reduction in total treatment waiting time, an improvement in tumor control or a survival benefit. Scan acquisition, clinical decisions, dose calculation and other planning stages still sit around the contouring task.
Putting the Commercial Benchmark in Context
Synaptiq also reports a separate comparison on the same 80-patient dataset used in a 2023 study of commercial AI contouring systems. That published study evaluated five vendors across breast, head-and-neck, lung and prostate cases; Synaptiq was not one of the five systems in the original paper.
In its subsequent comparison, Synaptiq reports a head-and-neck correction time of 2.7 minutes, compared with 4.4 minutes for the next-fastest system. Its description of the evaluation discusses both geometric agreement and editing effort. The distinction matters: a contour can have strong overall overlap with a reference while still requiring a clinically important local correction.
Integration With the Hospital’s Planning Systems
The company’s published intended-use documentation describes Mediq RT as a tool for trained radiation oncologists and medical physicists working with 3D CT images of adults who have an indication for radiotherapy. Qualified users review, edit and approve the structures before exporting them.
The software connects with treatment-planning systems and picture archiving and communication systems through DICOM, the standard used to exchange medical images and related data. Its browser-based viewer provides the workspace for reviewing contours, while the platform can run as a cloud service or on hospital premises.
This keeps Mediq RT focused on a defined part of planning. Reviewed structures move into the hospital’s subsequent dose-calculation and treatment-design workflow; the contouring software does not independently prescribe or deliver radiation.
A Workflow Tool With Clinicians in Control
Founded in Cluj-Napoca in 2021, Synaptiq says it now serves customers in 11 countries and has processed more than 63,000 patients in real-world clinical use. It plans to expand its European presence, develop further clinical evidence and pursue U.S. market entry through an FDA 510(k) submission.
The most useful promise of this approach is the combination of automation and correction. Generating a contour quickly is valuable when specialists can assess it, refine it efficiently and return it to the existing planning process. Mediq RT’s next stage of adoption will depend on how consistently that complete workflow performs across clinical settings.












